SJ-C1044
/ Samjin Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 28, 2023
Targeting RAF Isoforms and Tumor Microenvironments in RAS or BRAF Mutant Colorectal Cancers with SJ-C1044 for Anti-Tumor Activity.
(PubMed, Curr Issues Mol Biol)
- "Thus, SJ-C1044 shows immunomodulatory potential and the ability to enhance antitumor responses. The study underscores the therapeutic potential of SJ-C1044 as a novel pan-RAF inhibitor capable of targeting oncogenic signaling pathways and overcoming immune suppression in CRC."
Biomarker • Journal • Tumor microenvironment • Colorectal Cancer • Gastrointestinal Cancer • Immune Modulation • Oncology • Solid Tumor • BRAF • CSF1R • KDR • KRAS • RAS
1 to 1
Of
1
Go to page
1